Stockreport

Recursion to Report First Quarter 2024 Business Updates and Financial Results on May 9

Recursion Pharmaceuticals, Inc. - Class A  (RXRX) 
PDF SALT LAKE CITY, May 02, 2024 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, a [Read more]